Health Professionals Concerned At Further Delays To Gender Affirming Healthcare Guidelines
This is clear evidence of ideological interference in an operational, professional frontline medical resource that is being requested by the health sector. We reiterate our call for the Government to allow Te Whatu Ora Health New Zealand to publish these …
The Professional Association for Transgender Health Aotearoa (PATHA) is deeply concerned at further delays to the publication of updated Guidelines for Gender Affirming Healthcare in Aotearoa New Zealand.
PATHA has been informed by Te Whatu Ora | Health New Zealand that the updated Guidelines will not be published until the Minister of Health decides on whether to introduce regulations on the ability of medical professionals to prescribe puberty blockers as part of gender affirming healthcare.
The guideline's advice on prescribing puberty blockers was updated in November 2024 to reflect the Ministry of Health's position statement on the use of these medications. This advice spans just 6 of the total 182 pages of information contained in the guidelines. The guidance is evidence-based, aligns with international best practice and guidelines, and supports a holistic approach to gender affirming medical care for young people who need it.
'Medical professionals working in this area are constantly being asked by colleagues for clinical guidance on gender-affirming healthcare,' says Dr Rona Carroll, a Specialist General Practitioner and Vice-President of PATHA. 'By not publishing the updated guidelines, the government is stopping healthcare providers from being guided by evidence-based, up-to-date New Zealand specific information. We have been given no timeframe for when to expect a decision about the puberty blocker consultation or the updated guidelines. Considering how many other areas of health these guidelines include, and that the advice on prescribing puberty blockers is in line with the Ministry's position statement, the updated guidelines should be published immediately. I think clinicians would be providing safer care if they had access to these guidelines today.'
On Wednesday, 28 May, PATHA published an open letter calling on the Minister of Health, Simeon Brown and the Associate Minister for Health, Matt Doocey, to release the updated guidance.
This letter was signed by over 500 medical bodies, clinicians and community organisations. Signatories include the Royal New Zealand College of General Practitioners, the New Zealand Society of Endocrinology, the College of Child and Youth Nurses, and the Paediatric Society of New Zealand.
The evidence-based guidelines, which have been peer reviewed by clinicians with expertise in this care from within New Zealand and internationally, provide detailed information on a wide range of topics relevant to healthcare for transgender and non-binary people. This includes several revised chapters from the 2018 edition in line with emerging medical research.
'I'm proud of the amount of work the authors have put into these guidelines, bringing their extensive collective expertise into creating guidance that is broad and has a holistic view of transgender health,' says Jennifer Shields, PATHA President. 'These guidelines cover so much more than puberty blocker medication, and this information is important for all healthcare workers to have.'
'It is clear that there is no evidence-based justification for considering restrictions on prescribing puberty blockers to transgender young people,' Shields says. 'These medications continue to be prescribed to children for other indications, and limitations in the quality of the academic evidence are not unique to this care. Healthcare professionals are now left wondering if this government is being pulled into alarming 'culture war' trends away from best practice medical care, and into anti-transgender policies that lead to a reduction in patients' rights and freedoms, and set precedent for making clinical decisions based on political beliefs rather than what's best for patients.'
'This is clear evidence of ideological interference in an operational, professional frontline medical resource that is being requested by the health sector,' Carroll said. 'We reiterate our call for the Government to allow Te Whatu Ora Health New Zealand to publish these updated guidelines immediately.'
Background information
Statement on puberty blockers
On 21st November 2024, the Ministry of Health published a position statement on the use of puberty blockers in gender affirming care, emphasising that puberty blockers could continue to be prescribed when needed as part of interdisciplinary teams. The Government expressed an intention to explore further restrictions on access to this care, and opened public consultation on possible restrictions. This consultation closed on 20th January 2025.
A memo sent to then Minister of Health Shane Reti on 30 April 2024 was released to PATHA under the Official Information Act. In this memo, the Ministry of Health clarified that:
'There is currently no evidence that individual clinicians are prescribing [puberty blockers] outside of an interprofessional team.'
This shows that concerns about individual professionals prescribing puberty blockers inappropriately are unfounded, and current prescribing practices are already in line with the Ministry's position statement.
PATHA previously published a collective statement opposing the restrictions the Government is considering on the prescription of puberty blockers to transgender young people. This statement also received broad support from medical bodies, including the New Zealand Paediatrics Society and the New Zealand Society of Endocrinology. The statement reads [in part]:
'The Ministry of Health Evidence Brief identified that any evidence of harm associated with providing puberty-blocking medication is limited and inconclusive, and withholding this care may exacerbate gender dysphoria and negatively impact mental health. Equitable and non-discriminatory access to this care should be provided and maintained throughout the country.
Decisions about prescribing puberty blockers should continue to be made collaboratively between young people, their families or support people, and the health professionals involved in their care. These decisions are individualised, based on informed consent, and guided by professional training, clinical experience, and the best available evidence. Any move to restrict access to puberty blockers would be a political decision and not one based on clinical guidance from health experts in New Zealand and international best practice. Medical decisions should remain free from political interference.'
Background on puberty blockers
Puberty blockers are a medication called gonadotrophic releasing hormone (GnRH) agonists. They were developed in the 1980s for use in much younger children with precocious (early) puberty, and have been used in gender affirming care for over 20 years. They halt the development of secondary sexual characteristics, such as breast growth or voice deepening, and can relieve distress associated with these bodily changes for transgender young people. Puberty blockers have the benefit of allowing the young person time before making any decisions regarding starting on gender affirming hormone therapy.
The effect puberty blockers have on pausing pubertal changes is reversible. Once the puberty blocker medication has been stopped, puberty will resume as it would have done without medication.
All medications have known or potential risks, but evidence and experience to date does not raise significant concerns about the safety of puberty blockers. As is the case in all medical prescribing, risks, side effects and benefits of medications are discussed with patients as part of the informed consent process before prescribing.
There are also risks to not prescribing medications when they are indicated. Puberty results in irreversible physical changes, which can result in lifelong distress and gender dysphoria for some transgender people.
In every area of healthcare, decisions about treatment and medication prescribing take all of these aspects into account, and health professionals support patients and their families to weigh up the pros and cons for their individual situation. Gender affirming healthcare is no different. Decisions about whether to start puberty blockers are made between health professionals, young people and their whānau. These are healthcare decisions which should remain free from ideological political interference.
Clinicians who initiate puberty blockers should be experienced in providing gender affirming healthcare and working within an interdisciplinary team. It is essential that access to this care and to puberty blocker medication is maintained.
Topics covered by the updated Guidelines
Advice on the prescription of puberty blockers is a small portion of the content covered by the updated guidelines. The updated guidance also includes detailed information on a broad number of other areas of transgender health, including whānau support, creating inclusive clinical environments, non-medical and non-surgical gender affirmation, speech and language therapy, fertility and sexual health, mental wellbeing, gender-affirming hormone therapy, and detransition, as well as specific guidance for Māori, Pasifika, and refugee and asylum seeker trans people.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
2 hours ago
- NZ Herald
Tauranga cancer survivor urges bowel screening as almost half of kits not returned
When broken down by ethnicity, fewer than half of the kits sent to Māori, Pasifika and Asian people have been returned – 41.9%, 41.8% and 33.1%. Ferguson said she got upset hearing these statistics because there were 'so many people under the age of 60 that are screaming out to have those kits'. 'They know they have something wrong and they're just not being heard so therefore they're not getting screened because doctors are either saying 'you're too young' or 'it's something else'. 'That's wasted resources.' She said the scary thing with bowel cancer was someone could have it and have no symptoms. This was the case with Tauranga man Paul Blears, who said it was 'a hell of a shock' being diagnosed with bowel cancer after he used his screening kit. 'By doing that test, you are catching things early … which will avoid late-stage diagnosis,' Ferguson said. The National Bowel Screening Programme was introduced in the Health NZ Bay of Plenty region in May 2022. It was the last of the former 20 district health boards to introduce it after the programme started in July 2017. People are invited to join the programme at age 60 then sent a free home test kit every two years until age 74. The Government is gradually lowering the eligibility age to 58, to be in effect nationwide by March. The Health NZ data showed 103 cancers were detected between January 1, 2023, and May 26, 2025, and 78 surgeries were carried out to remove bowel cancer. Health NZ noted this may include people who had surgery who did not have their cancer detected via a screening kit, and that some patients may have had surgery in another district, or privately. Patients who chose chemotherapy treatment would not be recorded in surgery numbers, and others newly diagnosed may be waiting for surgery. Tauranga bowel cancer survivor Rachael Ferguson pictured in 2022. Photo / Andrew Warner Almost five years since her diagnosis, Ferguson said her scans and blood test results were 'great'. 'I feel great, which is the main thing,' said Ferguson, now aged 37. She gave birth to her son George in September 2022. 'He was such a good baby … he's really come into his own kind of personality now.' Ferguson said she had recently completed a reformer Pilates instructor course and would soon start teaching. She had also been doing paid partnerships on social media. With a background in early childhood education, she had done some relief teaching. 'After the diagnosis and also becoming a mum myself, I just felt like I was ready to leave that side of things. 'It's just been trying to find something else.' Bowel cancer is the second-highest cause of cancer death in New Zealand, killing about three Kiwis every day. One in 10 Kiwis diagnosed are under 50. New research by Bowel Cancer New Zealand showed one in four adults were unable to name a single symptom of bowel cancer, which Ferguson said was 'pretty concerning'. Bowel Cancer New Zealand chief executive Peter Huskinson said symptom awareness was the 'strongest line of defence', with screening currently limited to those aged 58 and older. 'Acting early, before symptoms become severe, can mean the difference between a treatable diagnosis at the GP and a late-stage emergency presentation. 'That free test in your mailbox doesn't just detect cancer – it can stop it before it starts,' he said. 'Don't leave it in a drawer. Put it by the loo and get it done.' Bowel cancer symptoms Bleeding from the bottom or in your poo A persistent change in bowel habits Ongoing, periodic or severe abdominal pain Unexplained weight loss or fatigue A lump or swelling in the abdomen Source: Bowel Cancer NZ Megan Wilson is a health and general news reporter for the Bay of Plenty Times and Rotorua Daily Post. She has been a journalist since 2021.
NZ Herald
4 hours ago
- NZ Herald
Northland news in brief: Whangārei bus hub reopens after upgrades
The new Rose St bus hub in central Whangārei features plenty of covered seating and shelter, four public toilets, a ticketing office and better pedestrian spaces. Photo / WDC The Rose St bus hub in central Whangārei has reopened to CityLink bus passengers after several months of construction. The project includes a new bus office, which is now open for all passenger queries, including topping up BeeCards, timetables and route questions. There are also new waiting areas, toilets and a pedestrian walkway from Rose St to Vine St. The Whangārei District Council-project was done in conjunction with Northland Regional Council and funded by NZTA Waka Kotahi. Heart specialist access improves Health Minister Simeon Brown is celebrating faster heart specialist access in Northland. The number of patients waiting for their first specialist assessment with a cardiologist dropped 36% since November 2023 and the number waiting longer than four months dropped 68%, he said. Measures to reduce the waitlist include running regular cardiac clinics at rural hospitals, prioritising those who have waited the longest and expanding local services, including the catheterisation lab at Whangārei Hospital. Brunch on Us Farmers, growers, and rural whānau are invited to join the Rural Support Te Tai Tokerau for Brunch on Us — a series of relaxed drop-in events across Northland. Running from Monday until September 3, from 11am to 1pm, the events are a chance for rural people to come together, enjoy some kai, and connect with others who understand the unique challenges of life on the land. For more information visit
RNZ News
12 hours ago
- RNZ News
Bangladesh dengue deaths top 100, August could be worse
Health experts are warning that August could bring an even more severe outbreak of the mosquito-borne disease. Photo: RNZ Bangladesh is experiencing a surge in dengue cases and deaths, with health experts warning that August could bring an even more severe outbreak of the mosquito-borne disease if urgent action is not taken. Dengue has killed 101 people and infected 24,183 so far this year, official data showed, placing a severe strain on the country's already overstretched healthcare system. A sharp rise in fatalities has accompanied the spike in cases. Nineteen people have already died of dengue so far in August, following 41 deaths in July, more than double June's 19 fatalities. "The situation is critical. The virus is already widespread across the country, and without aggressive intervention, hospitals will be overwhelmed," said Kabirul Bashar, an entomologist at Jahangirnagar University. "August could see at least three times as many cases as July, with numbers potentially peaking in September." Health officials are urging people to use mosquito repellents, sleep under nets, and eliminate stagnant water where mosquitoes breed. "We need coordinated spraying and community clean-up drives, especially in high-risk zones," Bashar said. Experts say climate change, along with warm, humid weather and intermittent rain, has created ideal breeding conditions for Aedes mosquitoes, the carriers of the dengue virus. While Dhaka remains a major hotspot, dengue is peaking across the country. Large numbers of infections are being reported from outside the capital, adding pressure to rural healthcare facilities with limited capacity to treat severe cases. Doctors warn that early medical attention is critical. Severe abdominal pain, vomiting, bleeding, or extreme fatigue should prompt immediate hospital visits to reduce the risk of complications or death. With the peak dengue season still ahead, health experts have stressed that community participation, alongside government-led mosquito control, will be critical in preventing what could become one of Bangladesh's worst outbreaks in years. The deadliest year on record was 2023, with 1,705 deaths and more than 321,000 infections reported. - Reuters
